Abstract: Disclosed are a spherical titanium silicalite catalyst and a preparation method therefor. The spherical titanium silicalite catalyst has the following composition: xTiO2·(1?x)SiO2/yMPO4, wherein x is equal to 0.0005-0.04, y is equal to 0.005-0.20, M is a metal element selected from alkaline earth metals, transition metals or combinations of two or more thereof. The spherical titanium silicalite catalyst is prepared by the following method: (i) providing titanium silicalite raw powder with the composition of xTiO2·(1?x)SiO2, wherein x is equal to 0.0005-0.04, and y is equal to 0.005-0.20; (ii) mixing silica sol, an organic template agent and phosphate in proportion to obtain an adhesive; and (iii) mixing the adhesive with the titanium silicalite raw powder, and carrying out spray-drying molding and firing to obtain the titanium silicalite catalyst.

Abstract: Disclosed are a composite oxide catalyst, a preparation method therefor, and a use thereof. The catalyst has the following general formula: MoFeaAlbPcOx, wherein a=0.25-0.5, b=0.001-0.2, c=0.001-0.6, and x is a number satisfying the valence of the general formula. The catalyst of the present invention has excellent low-temperature performance and thus has a long service life.

Abstract: A rotating seal-type liquid testing apparatus includes a lower cup component, an upper cup body, a top cover and a testing element. The lower cup component includes a lower cup body, a high liquid baffle, a low liquid baffle and a water-absorbing sealing plug. The low liquid baffle and the high liquid baffle divide a bottom of an inner cavity of the lower cup body into a reaction region and a cut-off region. An edge of a bottom surface of the inner cavity of the lower cup body is provided with a vent hole, and the vent hole is positioned in the cut-off region. The upper cup body is disposed in the lower cup body, a bottom surface of an inner cavity of the upper cup body is provided with a liquid outlet, and the liquid outlet is connected to the reaction region in the lower cup body.

Abstract: Provided is a tetravalent homodimeric bispecific antibody molecule simultaneously targeting an immune effector cell antigen CD3 and a tumor-associated antigen, wherein the bispecific antibody molecule contains, in order from N-terminus to C-terminus, a first single chain Fv, a second single chain Fv and a Fc fragment; wherein the first single chain Fv can specifically bind to the tumor-associated antigen, the second single chain Fv can specifically bind to CD3, and the first and the second single chain Fvs are connected by a linker peptide, while the second single chain Fv and the Fc fragment are directly connected or connected by a linker peptide; and the Fc fragment does not have effector functions such as CDC, ADCC and ADCP.

Abstract: Particulate compositions including a plurality of particles containing oil field chemicals encapsulated in a water soluble, water swellable, or water degradable matrix material are disclosed. The oil field chemicals may be corrosion inhibitors and the particulate composition may be prepared by spray drying mixtures of matrix material and oil field chemicals. The particulate compositions are designed to efficiently deliver the chemicals to the water phase of a multiphase environment, such as an oil/water environment.

Abstract: A rotating seal-type liquid testing apparatus includes a lower cup component, an upper cup body, a top cover and a testing element. The lower cup component includes a lower cup body, a high liquid baffle, a low liquid baffle and a water-absorbing sealing plug. The low liquid baffle and the high liquid baffle divide a bottom of an inner cavity of the lower cup body into a reaction region and a cut-off region. An edge of a bottom surface of the inner cavity of the lower cup body is provided with a vent hole, and the vent hole is positioned in the cut-off region. The upper cup body is disposed in the lower cup body, a bottom surface of an inner cavity of the upper cup body is provided with a liquid outlet, and the liquid outlet is connected to the reaction region in the lower cup body.

Abstract: A method for testing properties of a pressurized multiphase fluid sample containing at least hydrocarbons and water. The pressurized multiphase fluid sample is placed into a first pressurized chamber of a testing device. The water is separated from the hydrocarbons. At least part of the separated water is flowed through a first outlet in the first pressurized chamber and into a second pressurized chamber. The second pressurized chamber is optionally isolated from the first pressurized chamber. A pH level of the separated water is tested in the second pressurized chamber. Microbial activity and growth is tested for in the pressurized multiphase fluid in the first pressurized chamber. A pressure of the pressurized multiphase fluid is substantially maintained throughout the placing, separating, flowing, isolating, and testing steps.

Abstract: Carbon steels are desirable for many applications due to their hardness and low cost. Susceptibility toward corrosion can complicate the use of carbon steels, and there is presently no ready way to predict susceptibility toward corrosion for a given carbon steel under a particular set of corrosive conditions. Methods for predicting susceptibility toward corrosion and determining the suitability of a carbon steel may comprise: obtaining a group of carbon steel samples, each carbon steel sample having an unknown rate of corrosion and a microstructure; measuring a quantity of carbides within the microstructure of each carbon steel sample having an unknown rate of corrosion; and determining a relative order of susceptibility toward corrosion within the group of carbon steel samples based upon the quantity of carbides within the microstructure of each carbon steel sample.

Abstract: Capsules, systems and methods for delivering chemical components to multiphase environments are disclosed. The systems and methods utilize delivery capsules within which the chemical components are encapsulated. The chemical components may be corrosion inhibitors or biocides and the multiphase environment an oil/water environment, for example, within an oil transport pipeline. The systems and methods allow delivery of the capsules to targeted areas of the multiphase environment, for example, to a water phase or a water/metal interface.

Abstract: A method for testing properties of a pressurized multiphase fluid sample containing at least hydrocarbons and water. The pressurized multiphase fluid sample is placed into a first pressurized chamber of a testing device. The water is separated from the hydrocarbons. At least part of the separated water is flowed through a first outlet in the first pressurized chamber and into a second pressurized chamber. The second pressurized chamber is optionally isolated from the first pressurized chamber. A pH level of the separated water is tested in the second pressurized chamber. Microbial activity and growth is tested for in the pressurized multiphase fluid in the first pressurized chamber. A pressure of the pressurized multiphase fluid is substantially maintained throughout the placing, separating, flowing, isolating, and testing steps.

Abstract: The presently claimed invention applies to a genetic material processing, manipulation and transfection method and related product. The claimed invention relates to a method for changing the inherited characteristics of a cell through micro-beam chromosome modification. In one preferred embodiment, improvements to ‘genomic surgery’ are applied to modify source cell genetic material (101). Upon micro-beam welding of combined genetic material (301), transfection takes place either by using a laser beam with a wavelength of 337 nm to perforate a hole (303) on receptor cell (305) or micro-tube control technology is then applied to carry combined genetic material (301) through the micro-pore (303) into the receptor cell (305), inserting the welded chromosome segment (301) by injection. Combined genetic material may be placed anywhere within receptor cell (305), including transfection through nuclear hole (307) into the cell nucleus (311).

Abstract: The presently claimed invention applies to a genetic material processing and manipulation method and related product. The claimed invention relates to a method for changing the inherited characteristics of a cell through micro-beam chromosome modification. In one preferred embodiment, improvements to ‘genomic surgery’ are applied to modify source cell genetic material (101). Source cell (106) is stabilized through micro-pipette (102) applied negative pressure. Excised genetic material (101) undergoes a pre-cutting manipulation step (205) to enhance subsequent genetic manipulation. In an additional embodiment genetic material manipulation is aided by a spindle cutting step (303). The presently claimed invention provides a high quality alternate approach to directed genetic recombination without requiring the use of restriction enzymes and is used for chromosomal repair, removal of defects and new organism creation.

Abstract: The presently claimed invention applies to a genetic material processing and manipulation method and related product. The claimed invention relates to a method for changing the inherited characteristics of a cell through micro-beam chromosome modification. In one preferred embodiment, improvements to ‘genomic surgery’ are applied to modify source cell genetic material (101). Source cell (106) is stabilized through micro-pipette (102) applied negative pressure. Excised genetic material (101) undergoes a pre-cutting manipulation step (205) to enhance subsequent genetic manipulation. In an additional embodiment genetic material manipulation is aided by a spindle cutting step (303). The presently claimed invention provides a high quality alternate approach to directed genetic recombination without requiring the use of restriction enzymes and is used for chromosomal repair, removal of defects and new organism creation.

Abstract: An isolated protein sequence or peptide from the E2, E6 or E7 early coding region of human papillomavirus (HPV) that is soluble in an aqueous medium, and characterized by a relative paucity of tryptophan, methionine and cysteine residues, and a relative abundance of glycine and asparagine residues. Also disclosed are isolated protein sequences or peptides from the E2, E6 or E7 early coding regions of HPV 16 and 18 and methodologies for detecting or diagnosing cancer or cellular abnormalities. Detection or diagnosis of Cancer or cellular abnormalities may include detecting or diagnosing pre-cancerous or pre-malignant conditions, cervical dysplasia, cervical carcinoma, koilocytosis, hyperkeratosis, intraepithelial lesions, and other cancers.

Abstract: An isolated sequence or peptide isolated from an E2, E4, E6, E7 early or late coding region of human papillomavirus (HPV) that is soluble in aqueous medium, and characterized by a linkage to another protein sequence or peptide isolated from the E2, E4, E6, E7 early or late coding region of HPV by a spacer sequence, wherein the isolated protein sequence or peptide consists of more than 50% hydrophilic amino acids, and is recognized by a specific antibody of HPV. Also disclosed are isolated protein sequences or peptides from Harvey Ras (H-Ras), Kirsten Ras (K-Ras), and phosphatase and tensin homologue (PTEN) tumor suppressor proteins and Chlamydia trachomatis heat shock protein 60 (CHSP60 groEL1) and methods for detecting or diagnosing cancer or cellular abnormalities.

Abstract: An isolated protein sequence or peptide from the E2, E6 or E7 early coding region of human papillomavirus (HPV) that is soluble in an aqueous medium, and characterized by a relative paucity of tryptophan, methionine and cysteine residues, and a relative abundance of glycine and asparagine residues. Also disclosed are isolated protein sequences or peptides from the E2, E6 or E7 early coding regions of HPV 16 and 18 and methodologies for detecting or diagnosing cancer or cellular abnormalities. Detection or diagnosis of Cancer or cellular abnormalities may include detecting or diagnosing pre-cancerous or pre-malignant conditions, cervical dysplasia, cervical carcinoma, koilocytosis, hyperkeratosis, intraepithelial lesions, and other cancers.

Abstract: An isolated sequence or peptide isolated from an E2, E4, E6, E7 early or late coding region of human papillomavirus (HPV) that is soluble in aqueous medium, and characterized by a linkage to another protein sequence or peptide isolated from the E2, E4, E6, E7 early or late coding region of HPV by a spacer sequence, wherein the isolated protein sequence or peptide consists of more than 50% hydrophilic amino acids, and is recognized by a specific antibody of HPV. Also disclosed are isolated protein sequences or peptides from Harvey Ras (H-Ras), Kirsten Ras (K-Ras), and phosphatase and tensin homologue (PTEN) tumor suppressor proteins and Chlamydia trachomatis heat shock protein 60 (CHSP60 groEL1) and methods for detecting or diagnosing cancer or cellular abnormalities.

Abstract: An isolated protein sequence or peptide from the E2, E6 or E7 early coding region of human papillomavirus (HPV) that is soluble in an aqueous medium, and characterized by a relative paucity of tryptophan, methionine and cysteine residues, and a relative abundance of glycine and asparagine residues. Also disclosed are isolated protein sequences or peptides from the E2, E6 or E7 early coding regions of HPV 16 and 18 and methodologies for detecting or diagnosing cancer or cellular abnormalities. Detection or diagnosis of Cancer or cellular abnormalities may include detecting or diagnosing pre-cancerous or pre-malignant conditions, cervical dysplasia, cervical carcinoma, koilocytosis, hyperkeratosis, intraepithelial lesions, and other cancers.

Abstract: An isolated protein sequence or peptide from the E2, E6 or E7 early coding region of human papillomavirus (HPV) that is soluble in an aqueous medium, and characterized by a relative paucity of tryptophan, methionine and cysteine residues, and a relative abundance of glycine and asparagine residues. Also disclosed are isolated protein sequences or peptides from the E2, E6 or E7 early coding regions of HPV 16 and 18 and methodologies for detecting or diagnosing cancer or cellular abnormalities. Detection or diagnosis of Cancer or cellular abnormalities may include detecting or diagnosing pre-cancerous or pre-malignant conditions, cervical dysplasia, cervical carcinoma, koilocytosis, hyperkeratosis, intraepithelial lesions, and other cancers.

Abstract: The invention provides peptides designed to be highly reactive with antibodies from patients infected with oncogenic HPV. Also disclosed is a method for their use in an immunoassay to detect HPV infection and HPV associated epithelial cell abnormalities, most notably those associated with premalignant and malignant epithelial cell lesions. The peptides and the disclosed method are particularly useful for diagnosing carcinomas of the uterine cervix, or pre-stages thereof, or those at risk of development of carcinoma. The detection can be effected on blood samples, or other bodily fluid or tissue, by ascertaining the presence of IgA or IgG antibodies against HPV 16 and/or 18.